- Home
- ALEC vs OTLY Comparison
ALEC vs OTLY Comparison
Compare ALEC & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | OTLY |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.4M | 255.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALEC | OTLY |
|---|---|---|
| Price | $1.51 | $8.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.83 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 703.1K | 115.9K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | $7.91 |
| Revenue Next Year | $29.87 | $5.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $8.08 |
| 52 Week High | $3.40 | $18.84 |
Technical Indicators
Market Signals| Indicator | ALEC | OTLY |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 26.26 |
| Support Level | $1.14 | $8.09 |
| Resistance Level | $1.60 | $12.58 |
| Average True Range (ATR) | 0.15 | 0.43 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 10.71 | 2.35 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About OTLY Oatly Group AB
Oatly Group AB produces and distributes oat-based food and beverage products. Its offerings include milk, cooking creams, spreads, and yogurts. The company's products are sold through retail stores, coffee shops, and restaurants across multiple countries. It generates revenue from sales of oatmilk and other oat-based products. The company's geographical segments include Europe & International, North America and Greater China. The Europe & International segment is its maximum revenue-producing segment, followed by the North America and Greater China segments.